Search Medical Condition
Please enter condition
Please choose location from dropdown
Clear Trial Filters

Bernau, Germany Clinical Trials

A listing of Bernau, Germany clinical trials actively recruiting patients volunteers.

RESULTS

Found (12) clinical trials

BAROSTIM THERAPY In Heart Failure With Preserved Ejection Fraction

Summary The CVRx BAROSTIM THERAPY in Heart Failure with Preserved Ejection Fraction (HFpEF) Registry will be performed with subjects who have been recently implanted with the BAROSTIM NEO System in accordance with CE-Mark approved criteria for resistant hypertension and have evidence of HFpEF per the registry enrollment criteria. Subjects must …

Phase N/A

0.0 miles

Learn More »

BAROSTIM THERAPY in Heart Failure With Reduced Ejection Fraction

Summary The CVRx BAROSTIM THERAPY in Heart Failure with Reduced Ejection Fraction (HFrEF) Registry will be performed with subjects who have been recently implanted with the BAROSTIM NEO System in accordance with CE-Mark approved criteria for heart failure. Subjects must be enrolled within 30 days from implant. Up to 500 …

Phase N/A

0.0 miles

Learn More »

BAROSTIM THERAPY In Resistant Hypertension

Summary The CVRx BAROSTIM THERAPY in Resistant Hypertension Registry will be performed with subjects who have been recently implanted with the BAROSTIM NEO System in accordance with CE-Mark approved criteria for resistant hypertension. Subjects must be enrolled within 30 days from implant. Up to 500 subjects will be enrolled at …

Phase N/A

0.0 miles

Learn More »

MiCLASP Post Market Clinical Follow-Up (PMCF) Study

The objectives of this clinical study are to collect data on the safety of the Edwards PASCAL Transcatheter Valve Repair System in transcatheter mitral valve repair and on the effectiveness of the Edwards PASCAL System in improving MR and improving functional status and quality of life in a post market …

Phase N/A

0.0 miles

Learn More »

Observational Study to Determine How Physicians Make Treatment Decisions in Patients Treated With Tofacitinib for Moderate to Severe Active Rheumatoid Arthritis

This non-interventional study aims to identify key factors that are driving treatment decisions by rheumatologists in the treatment of rheumatoid arthritis (RA) patients starting treatment with Tofacitinib in a real world setting.

Phase N/A

0.0 miles

Learn More »

Reaching for Evidence-baSed Chemotherapy Use in Endocrine Sensitive Breast Cancer

The goal of the study is to receive current and comprehensive information about the diseasefree (remote metastasis free and recurrence free) interval of EndoPredict low risk patients. The study is organized and managed by the NOGGO e.V. (North Eastern German Society of Gynaecological Oncology e.V.) study coordination office under the …

Phase N/A

5.34 miles

Learn More »

Praegnant Breast Cancer: Early/Advanced/Metastatic

Among patients with breast cancer the subgroup of patients with metastases are considered the group of patients with the worst prognosis. Not only regard-ing therapy decisions but also with regard to quality assured healthcare and health economics this entity of patients remains a challenge. Recently, novel advances in breast cancer …

Phase N/A

5.34 miles

Learn More »

International HIT-MED Registry (I-HIT-MED)

The following patients can be included in this registry: Children and adults with Medulloblastoma (MB) Ependymoma CNS-primitive neuroectodermal tumours (CNS-PNET) including CNS neuroblastoma, CNS ganglioneuroblastoma, Medulloepithelioma, Ependymoblastoma, CNS-PNET not otherwise specified (NOS) Pineoblastoma Pineal parenchymal tumour of intermediate differentiation Papillary tumour of the pineal region Who are not included in …

Phase N/A

5.34 miles

Learn More »

A Safety Study of Lenalidomide in Previously Untreated Adult Multiple Myeloma Patients Who Are Not Eligible for Transplant

This post authorization safety study is designed as prospective non interventional study for patients with newly diagnosed multiple myeloma who are not eligible for transplant. The objective is to compare the incidence of cardiovascular events between patients treated with a first-line lenalidomide containing regimen and those treated with a first-line …

Phase N/A

5.34 miles

Learn More »

Urinary T Lymphocytes Predict Renal Flares in Patients With Inactive ANCA-associated Glomerulonephritis

Data of previous studies have shown that counts of urinary T lymphocyte subsets correlate with disease activity in several immunological renal diseases, e.g. ANCA-associated glomerulonephritis. Thus, study authors hypothesise that CD4+, respectively CD8+, T effector memory lymphocytes found in urine samples of patients with inactive ANCA-vasculitis predict subsequent renal flares. …

Phase N/A

5.34 miles

Learn More »